Skip to main content

and
  1. Article

    Open Access

    Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years

    Upadacitinib (UPA) is a Janus kinase inhibitor that has demonstrated efficacy in moderate-to-severe rheumatoid arthritis (RA) with an acceptable safety profile. We investigated laboratory parameter changes in ...

    Christina Charles-Schoeman, Jon T. Giles, Nancy E. Lane in Rheumatology and Therapy (2024)

  2. Article

    Open Access

    Correction to: Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment

    James Oliver, Nisha Nair, Gisela Orozco, Samantha Smith in Arthritis Research & Therapy (2021)

  3. Article

    Open Access

    Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment

    Despite the success of TNF-inhibitor therapy in rheumatoid arthritis treatment, up to 40% of patients fail to respond adequately. This study aimed to identify transcriptome-based biomarkers of adalimumab respo...

    James Oliver, Nisha Nair, Gisela Orozco, Samantha Smith in Arthritis Research & Therapy (2021)

  4. Article

    Open Access

    Rheumatoid arthritis response to treatment across IgG1 allotype – anti-TNF incompatibility: a case-only study

    We have hypothesized that incompatibility between the G1m genotype of the patient and the G1m1 and G1m17 allotypes carried by infliximab (INX) and adalimumab (ADM) could decrease the efficacy of these anti-tum...

    Ariana Montes, Eva Perez-Pampin, Federico Navarro-Sarabia in Arthritis Research & Therapy (2015)

  5. Article

    Open Access

    A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis

    Progression of joint destruction in rheumatoid arthritis (RA) is partly heritably; 45 to 58% of the variance in joint destruction is estimated to be explained by genetic factors. The binding of RANKL (Receptor...

    Rachel Knevel, Diederik PC de Rooy, Tore Saxne in Arthritis Research & Therapy (2014)

  6. Article

    Open Access

    Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

    In many European countries, restrictions exist around the prescription of anti-tumor necrosis factor (anti-TNF) treatments for rheumatoid arthritis (RA). Eligibility and response to treatment is assessed by us...

    Darren Plant, Ibrahim Ibrahim, Mark Lunt, Stephen Eyre in Arthritis Research & Therapy (2012)

  7. Article

    Open Access

    Overlap** genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease

    Genome wide association studies, replicated by numerous well powered validation studies, have revealed a large number of loci likely to play a role in susceptibility to many multifactorial diseases. It is now ...

    Stephen Eyre, Anne Hinks, John Bowes, Edward Flynn in Arthritis Research & Therapy (2010)

  8. Article

    Open Access

    Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis

    Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease primarily involving the synovium. Evidence in recent years has suggested that the bone marrow (BM) may be involved, and may even be the initia...

    Sindhu T Mohanty, Lucksy Kottam, Alessandra Gambardella in Arthritis Research & Therapy (2010)

  9. Article

    Complex genetic association of 6q23 with autoimmune rheumatic conditions

    In the paper by Dieguez-Gonzalez and colleagues in the present issue of Arthritis Research & Therapy, the results of a detailed genetic investigation of the recently identified rheumatoid arthritis and systemic l...

    James R Maxwell, Isobel R Gowers, Anthony G Wilson in Arthritis Research & Therapy (2009)

  10. Article

    Open Access

    Lack of association or interactions between the IL-4, IL-4Rα and IL-13 genes, and rheumatoid arthritis

    A feature of rheumatoid arthritis (RA) is an imbalance between proinflammatory and anti-inflammatory cytokines. Several recent studies have implicated polymorphism in the IL-4 signalling pathway in the develop...

    Ioanna Marinou, Simon H Till, David J Moore in Arthritis Research & Therapy (2008)

  11. Article

    Open Access

    The interferon induced with helicase domain 1 A946T polymorphism is not associated with rheumatoid arthritis

    An important feature of autoimmune diseases is the overlap of pathophysiological characteristics. Clustering of autoimmune diseases in families suggests that genetic variants may contribute to autoimmunity. Th...

    Ioanna Marinou, Douglas S Montgomery, Marion C Dickson in Arthritis Research & Therapy (2007)

  12. Article

    Open Access

    Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis

    Several recent publications have established a strong association between anti-cyclic citrullinated peptide antibody (anti-CCP)-positive rheumatoid arthritis (RA) and carriage of shared epitope (SE) alleles. A...

    Devesh Mewar, Annabel Coote, David J Moore, Ioanna Marinou in Arthritis Research & Therapy (2006)